Search

Your search keyword '"Nicholson, Andrew G."' showing total 1,702 results

Search Constraints

Start Over You searched for: Author "Nicholson, Andrew G." Remove constraint Author: "Nicholson, Andrew G."
1,702 results on '"Nicholson, Andrew G."'

Search Results

1. The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma

2. PCSK6 and Survival in Idiopathic Pulmonary Fibrosis

3. Radiomics-based decision support tool assists radiologists in small lung nodule classification and improves lung cancer early diagnosis

4. Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx

5. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the Classification of Residual Tumor After Resection for the Forthcoming (Ninth) Edition of the TNM Classification of Lung Cancer

6. The International Association for the Study of Lung Cancer (IASLC) Staging Project for Lung Cancer: Recommendation to Introduce Spread Through Air Spaces as a Histologic Descriptor in the Ninth Edition of the TNM Classification of Lung Cancer. Analysis of 4061 Pathologic Stage I NSCLC

7. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer

8. Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial

11. Systemic Sclerosis and the Lung

12. The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: Proposals for the N and the M Components for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors

13. The evolution of lung cancer and impact of subclonal selection in TRACERx

14. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

15. The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: A Re-Assessment of the International Thymic Malignancy Interest Group/International Association for the Study of Lung Cancer Lymph Node Map for Thymic Epithelial Tumors for the Forthcoming Ninth Edition of the TNM Classification of Malignant Tumors

16. The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: Proposal for a Stage Classification for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors

17. The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Proposal for the T Component for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors

18. The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: An Overview of the Central Database Informing Revision of the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors

19. Integration and Application of Clinical Practice Guidelines for the Diagnosis of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis

20. Author Correction: Integrated genomics point to immune vulnerabilities in pleural mesothelioma

21. The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

22. The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?

25. Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists

26. The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis

27. The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC

28. Landscape of cancer biomarker testing in England following genomic services reconfiguration: insights from a nationwide pathologist survey.

29. Low bleeding rates following transbronchial lung cryobiopsy in unclassifiable interstitial lung disease.

30. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

31. The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

32. Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society

33. Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center

34. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

35. PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

37. The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non–Small Cell Lung Cancer

38. The International Association for the Study of Lung Cancer Thymic Tumors Staging Project: The Impact of the Eighth Edition of the Union for International Cancer Control and American Joint Committee on Cancer TNM Stage Classification of Thymic Tumors

39. Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel

41. EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach

43. International reproducibility study of thymic epithelial tumors staging: pT stage is an issue. proposals for improvement. A RYTHMIC/ITMIG study

44. Overnight desaturation in interstitial lung diseases: links to pulmonary vasculopathy and mortality

45. Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19

47. Integrated genomics point to immune vulnerabilities in pleural mesothelioma

48. Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization

49. Pathologic Considerations and Standardization in Mesothelioma Clinical Trials

Catalog

Books, media, physical & digital resources